Literature DB >> 26403766

Short-term exercise training attenuates acute doxorubicin cardiotoxicity.

Chia-Ying Lien1, Brock T Jensen2, David S Hydock3, Reid Hayward4.   

Abstract

Doxorubicin (DOX) is a potent and widely used antineoplastic agent. Despite the efficacy of DOX, its clinical use is limited by a dose-dependent cardiotoxicity. Chronic exercise training has been shown to protect against DOX-induced cardiotoxicity. It is less clear whether short-term exercise can attenuate DOX-induced dysfunction. The purposes of this study were to determine if short-term wheel running and treadmill exercise training can attenuate the cardiac dysfunction that accompanies DOX treatment and to investigate possible mechanisms that may be involved with any protective effects of exercise. Male Sprague-Dawley rats engaged in a short-term 5-day voluntary wheel running (WR) or treadmill exercise (TM) regimen. Following the exercise preconditioning period, animals received either 10 or 15 mg/kg of DOX or an equivalent volume of saline (SAL). Five days after DOX/SAL exposure, cardiac function was examined. Western immunoblotting was used to quantify left ventricular sarcoendoplasmic reticulum calcium-ATPase 2a (SERCA2a) protein expression. Exercise preconditioning attenuated in vivo and ex vivo cardiac dysfunction observed with DOX treatment alone. Specifically, short-term treadmill exercise (TM + DOX10, 56 ± 4%; TM + DOX15, 48 ± 5%) and voluntary wheel running (WR + DOX10, 51 ± 5%; WR + DOX15, 45 ± 3%) consistently preserved fractional shortening when compared to sedentary (SED) animals treated with DOX (SED + DOX10, 48 ± 4%; SED + DOX15, 39 ± 6%). Likewise, both exercise protocols preserved left ventricular developed pressure (TM + DOX10, 115 ± 6 mmHg; TM + DOX15, 85 ± 5 mmHg; WR + DOX10, 92 ± 12 mmHg; WR + DOX15, 91 ± 8 mmHg) when compared to SED animals treated with DOX (SED + DOX10, 79 ± 6 mmHg; SED + DOX15, 69 ± 7 mmHg). SERCA2a expression was also preserved in TM + DOX and WR + DOX. These findings suggest that short-term exercise prior to DOX treatment may be a valuable adjuvant therapy to offset acute cardiotoxicities and that maintaining calcium handling in cardiomyocytes may be responsible, in part, for the preservation in cardiac function.

Entities:  

Keywords:  Adriamycin; Cardioprotection; Chemotherapy; Physical activity

Mesh:

Substances:

Year:  2015        PMID: 26403766     DOI: 10.1007/s13105-015-0432-x

Source DB:  PubMed          Journal:  J Physiol Biochem        ISSN: 1138-7548            Impact factor:   4.158


  39 in total

1.  Effect of voluntary exercise on maximal oxygen uptake in young female Fischer 344 rats.

Authors:  H Yano; L Yano; S Kinoshita; E Tsuji
Journal:  Jpn J Physiol       Date:  1997-02

Review 2.  Cardiac toxicity of antineoplastic anthracyclines.

Authors:  Riccardo Zucchi; Romano Danesi
Journal:  Curr Med Chem Anticancer Agents       Date:  2003-03

3.  Moderate endurance training prevents doxorubicin-induced in vivo mitochondriopathy and reduces the development of cardiac apoptosis.

Authors:  António Ascensão; José Magalhães; José M C Soares; Rita Ferreira; Maria J Neuparth; Franklim Marques; Paulo J Oliveira; José A Duarte
Journal:  Am J Physiol Heart Circ Physiol       Date:  2005-03-25       Impact factor: 4.733

4.  Evaluation of left ventricular function in long-term survivors of childhood Hodgkin disease.

Authors:  Diana Iarussi; Carlo Pisacane; Paolo Indolfi; Fiorina Casale; Vincenzo Martino; Maria Teresa Di Tullio
Journal:  Pediatr Blood Cancer       Date:  2005-10-15       Impact factor: 3.167

5.  Effects of body temperature during exercise training on myocardial adaptations.

Authors:  M B Harris; J W Starnes
Journal:  Am J Physiol Heart Circ Physiol       Date:  2001-05       Impact factor: 4.733

6.  The role of frataxin in doxorubicin-mediated cardiac hypertrophy.

Authors:  Shravanthi Mouli; Gayani Nanayakkara; Abdullah AlAlasmari; Haitham Eldoumani; Xiaoyu Fu; Avery Berlin; Madhukar Lohani; Ben Nie; Robert D Arnold; Andreas Kavazis; Forrest Smith; Ronald Beyers; Thomas Denney; Muralikrishnan Dhanasekaran; Juming Zhong; John Quindry; Rajesh Amin
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-07-24       Impact factor: 4.733

7.  Doxorubicin-induced markers of myocardial autophagic signaling in sedentary and exercise trained animals.

Authors:  Ashley J Smuder; Andreas N Kavazis; Kisuk Min; Scott K Powers
Journal:  J Appl Physiol (1985)       Date:  2013-05-23

8.  Exercise training attenuates acute doxorubicin-induced cardiac dysfunction.

Authors:  Adam J Chicco; Carole M Schneider; Reid Hayward
Journal:  J Cardiovasc Pharmacol       Date:  2006-02       Impact factor: 3.105

9.  Exercise preconditioning protects against doxorubicin-induced cardiac dysfunction.

Authors:  David S Hydock; Chia-Ying Lien; Carole M Schneider; Reid Hayward
Journal:  Med Sci Sports Exerc       Date:  2008-05       Impact factor: 5.411

10.  Switching to a low-fat diet attenuates the intensified doxorubicin cardiotoxicity associated with high-fat feeding.

Authors:  David S Hydock; Chia-Ying Lien; Brock T Jensen; Carole M Schneider; Reid Hayward
Journal:  Cancer Chemother Pharmacol       Date:  2013-04-09       Impact factor: 3.333

View more
  9 in total

1.  Exercise stimulates beneficial adaptations to diminish doxorubicin-induced cellular toxicity.

Authors:  Ashley J Smuder
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2019-08-28       Impact factor: 3.619

Review 2.  Exercise Training and Cardiovascular Health in Cancer Patients.

Authors:  Ray W Squires; Adam M Shultz; Joerg Herrmann
Journal:  Curr Oncol Rep       Date:  2018-03-10       Impact factor: 5.075

3.  Nanomicelles loaded with doxorubicin and curcumin for alleviating multidrug resistance in lung cancer.

Authors:  Yue Gu; Jing Li; Yang Li; Lei Song; Dan Li; Liping Peng; Ying Wan; Shucheng Hua
Journal:  Int J Nanomedicine       Date:  2016-11-03

4.  Breast cancer treatment-associated cardiovascular toxicity and effects of exercise countermeasures.

Authors:  Anthony F Yu; Lee W Jones
Journal:  Cardiooncology       Date:  2016-02-25

5.  Effects of Calorie Restriction and Voluntary Exercise on Doxorubicin-Induced Cardiotoxicity.

Authors:  Stephanie E Hall; Ashley J Smuder; Reid Hayward
Journal:  Integr Cancer Ther       Date:  2019 Jan-Dec       Impact factor: 3.279

6.  Cardioprotective effects of exercise training on doxorubicin-induced cardiomyopathy: a systematic review with meta-analysis of preclinical studies.

Authors:  Paola Victória da Costa Ghignatti; Laura Jesuíno Nogueira; Alexandre Machado Lehnen; Natalia Motta Leguisamo
Journal:  Sci Rep       Date:  2021-03-18       Impact factor: 4.379

Review 7.  Exercise Cardio-Oncology: Exercise as a Potential Therapeutic Modality in the Management of Anthracycline-Induced Cardiotoxicity.

Authors:  Dong-Woo Kang; Rebekah L Wilson; Cami N Christopher; Amber J Normann; Oscar Barnes; Jordan D Lesansee; Gyuhwan Choi; Christina M Dieli-Conwright
Journal:  Front Cardiovasc Med       Date:  2022-01-14

8.  EXercise to prevent AnthrCycline-based Cardio-Toxicity (EXACT) in individuals with breast or hematological cancers: a feasibility study protocol.

Authors:  Melanie R Keats; Scott A Grandy; Nicholas Giacomantonio; David MacDonald; Miroslaw Rajda; Tallal Younis
Journal:  Pilot Feasibility Stud       Date:  2016-08-05

9.  Efficacy of Physical Exercise to Offset Anthracycline-Induced Cardiotoxicity: A Systematic Review and Meta-Analysis of Clinical and Preclinical Studies.

Authors:  Willeke R Naaktgeboren; David Binyam; Martijn M Stuiver; Neil K Aaronson; Arco J Teske; Wim H van Harten; Wim G Groen; Anne M May
Journal:  J Am Heart Assoc       Date:  2021-09-02       Impact factor: 5.501

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.